Does NEMOLIZUMAB Cause Intentional product use issue? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Intentional product use issue have been filed in association with NEMOLIZUMAB (NEMLUVIO). This represents 2.7% of all adverse event reports for NEMOLIZUMAB.
10
Reports of Intentional product use issue with NEMOLIZUMAB
2.7%
of all NEMOLIZUMAB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Intentional product use issue From NEMOLIZUMAB?
Of the 10 reports, 1 (10.0%) resulted in death, 1 (10.0%) required hospitalization.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEMOLIZUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does NEMOLIZUMAB Cause?
Pemphigoid (51)
Death (33)
Erythema (26)
Dermatitis exfoliative generalised (25)
Erythema multiforme (25)
Dermatitis atopic (23)
Pneumonia (14)
Blister (12)
Cellulitis (12)
Eczema herpeticum (12)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which NEMOLIZUMAB Alternatives Have Lower Intentional product use issue Risk?
NEMOLIZUMAB vs NEMOLIZUMAB-ILTO
NEMOLIZUMAB vs NEOMYCIN
NEMOLIZUMAB vs NEORAL
NEMOLIZUMAB vs NEOSTIGMINE
NEMOLIZUMAB vs NEOSTIGMINE METHYLSULFATE